Home > Boards > Stock Clubs > Technical Analysis > QualityStocks

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
QualityStocks Member Profile
Member Level 
Followed By 424
Posts 40,377
Boards Moderated 2
Alias Born 05/08/06
160x600 placeholder
QualityStocks Member Level  Thursday, 05/16/19 06:07:29 PM
Re: None
Post # of 23939 
Compensated Awareness Post - View Disclaimer
QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q1 2019 Financial Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, on Wednesday announced that it will host a teleconference to discuss its first quarter 2019 financial results and provide a business update. The call is scheduled for May 16, 2019 at 4:30 PM ET. Interested parties may listen to the teleconference live by dialing (844) 602-0380 (North America) or (862) 298-0970 (International) and stating the following verbal passcode: PBI First Quarter 2019 Financial Call & Business Update. A replay will be available beginning Friday, May 17, 2019, and will be accessible for 30 days via telephone and the company’s website. Interested parties may listen to the telephone replay by dialing (877) 481-4010 (North America) or (919) 882-2331 (International) and entering replay passcode: 49215.

To view the full press release, visit http://ibn.fm/mQ0oB

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist